| Literature DB >> 15355759 |
Thomas W McAllister1, Tim A Ahles, Andrew J Saykin, Robert J Ferguson, Brenna C McDonald, Lionel D Lewis, Laura A Flashman, C Harker Rhodes.
Abstract
Increasing evidence suggests that systemic cancer chemotherapy can have significant long-term effects on cognition, particularly on verbal learning, memory, attention, and speed of information processing. These deficits can be a source of significant distress to survivors. There is much less known about the mechanisms, predisposing vulnerabilities, and treatment of these deficits. We will summarize current knowledge of chemotherapy-associated cognitive deficits. Emerging theories about the role of selected genetic polymorphisms in heightening the vulnerability to chemotherapy-induced cognitive decline will be described.Entities:
Mesh:
Year: 2004 PMID: 15355759 DOI: 10.1007/s11920-004-0023-y
Source DB: PubMed Journal: Curr Psychiatry Rep ISSN: 1523-3812 Impact factor: 5.285